MacClesfield, United Kingdom

Ralph Howe

This inventor holds 10 USPTO granted patents. Top assignees: Imperial Chemical Industries Limited, Zeneca Limited. Active years: 1980-1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ralph Howe. Retrieved from https://idiyas.com/inventor/ralph-howe

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.2

ph-index = 9

Forward Citations = 226(Granted Patents)


Location History:

  • Macclesfield, GB (1980 - 1996)
  • Macelesfield, GB (1996)

Company Filing History:


Years Active: 1980-1996

Loading Chart...
10 patents (USPTO):Explore Patents

Title: Ralph Howe: Innovator in Chemical Compounds

Introduction

Ralph Howe is a notable inventor based in MacClesfield, GB. He has made significant contributions to the field of chemical compounds, holding a total of 10 patents. His work primarily focuses on compounds that serve various therapeutic utilities.

Latest Patents

Among his latest patents, Ralph Howe has developed chemical compounds described as β3-adrenoceptor agonists. These compounds are recognized for their anti-obesity and hypoglycaemic properties, along with other related therapeutic utilities. The processes for their preparation and the compositions containing them are also detailed in his patents.

Career Highlights

Ralph Howe has had a distinguished career, working with prominent companies such as Imperial Chemical Industries Limited and Zeneca Limited. His expertise in chemical compounds has led to innovative solutions in the pharmaceutical industry.

Collaborations

Throughout his career, Ralph has collaborated with notable coworkers, including Balbir S Rao and Brian R Holloway. These collaborations have contributed to the advancement of his research and inventions.

Conclusion

Ralph Howe's contributions to the field of chemical compounds highlight his innovative spirit and dedication to improving therapeutic options. His patents and collaborations reflect a commitment to advancing science and technology in meaningful ways.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…